PMB 511: Biotechnology in Vaccine Development

The principle of vaccine production involves the use of microorganisms or their components, which are inactivated or attenuated, to stimulate an immune response in the host.

Inactivating microorganisms in vaccine production ensures that the pathogens are unable to cause disease while still stimulating an immune response.

Formulation in vaccine development involves combining the vaccine antigen with adjuvants, preservatives, and stabilizers to enhance immunogenicity and shelf life.

<p>Quality control and lot release ensure that the vaccine meets predetermined standards of safety, purity, and potency before release for human use.</p> Signup and view all the answers

<p>Recombinant vaccines offer improved safety, efficacy, and scalability, allowing for rapid development and production of vaccines against emerging diseases.</p> Signup and view all the answers

<p>Uturu</p> Signup and view all the answers

<p>process</p> Signup and view all the answers

<p>activities</p> Signup and view all the answers

<p>safety</p> Signup and view all the answers

<p>genetic</p> Signup and view all the answers